Antibody-induced Arthritis: Disease Mechanisms and Genes Involved at the Effector Phase of Arthritis

Overview

Journal Arthritis Res Ther

Publisher Biomed Central

Specialty Rheumatology

Date 2007 Jan 27

PMID 17254316

Citations 64

Authors

Kutty Selva Nandakumar

Rikard Holmdahl

Affiliations

Soon will be listed here.

Abstract

During the development of rheumatoid arthritis (RA) autoantibodies to IgG-Fc, citrullinated proteins, collagen type II (CII), glucose 6 phosphoisomerase (G6PI) and some other self-antigens appear. Of these, a pathogenic effect of the anti-CII and anti-G6PI antibodies is well demonstrated using animal models. These new antibody mediated arthritis models have proven to be very useful for studies involved in understanding the molecular pathways of the induction of arthritis in joints. Both the complement and FcgammaR systems have been found to play essential roles. Neutrophils and macrophages are important inflammatory cells and the secretion of tumour necrosis factor-alpha and IL-1beta is pathogenic. The identification of the genetic polymorphisms predisposing to arthritis is important for understanding the complexity of arthritis. Disease mechanisms and gene regions studied using the two antibody-induced arthritis mouse models (collagen antibody-induced arthritis and serum transfer-induced arthritis) are compared and discussed for their relevance in RA pathogenesis.

Citing Articles

Active immunotherapy for C5a-mediated inflammation using adjuvant-free self-assembled peptide nanofibers.

Hainline K, Freire Haddad H, Gilpin A, Curvino E, Varghese S, Collier J Acta Biomater. 2024; 179:83-94.

PMID: 38447809 PMC: 11045302. DOI: 10.1016/j.actbio.2024.02.042.

Aberrant Activation of Immune and Non-Immune Cells Contributes to Joint Inflammation and Bone Degradation in Rheumatoid Arthritis.

Nandakumar K, Fang Q, Wingbro Agren I, Bejmo Z Int J Mol Sci. 2023; 24(21).

PMID: 37958864 PMC: 10648236. DOI: 10.3390/ijms242115883.

A subset of type-II collagen-binding antibodies prevents experimental arthritis by inhibiting FCGR3 signaling in neutrophils.

Xu Z, Xu B, Lundstrom S, Moreno-Giro A, Zhao D, Martin M Nat Commun. 2023; 14(1):5949.

PMID: 37741824 PMC: 10517938. DOI: 10.1038/s41467-023-41561-7.

Control of myeloid cell functions by nociceptors.

Hanc P, Messou M, Wang Y, von Andrian U Front Immunol. 2023; 14:1127571.

PMID: 37006298 PMC: 10064072. DOI: 10.3389/fimmu.2023.1127571.

Vaccines prevent reinduction of rheumatoid arthritis symptoms in collagen-induced arthritis mouse model.

Thumsi A, Swaminathan S, Mangal J, Suresh A, Acharya A Drug Deliv Transl Res. 2023; 13(7):1925-1935.

PMID: 36971998 PMC: 10899801. DOI: 10.1007/s13346-023-01333-8.

References

Kato H, Nishida K, Yoshida A, Takada I, McCown C, Matsuo M . Effect of NOS2 gene deficiency on the development of autoantibody mediated arthritis and subsequent articular cartilage degeneration. J Rheumatol. 2003; 30(2):247-55. View

Choe J, Crain B, Wu S, Corr M . Interleukin 1 receptor dependence of serum transferred arthritis can be circumvented by toll-like receptor 4 signaling. J Exp Med. 2003; 197(4):537-42. PMC: 2193870. DOI: 10.1084/jem.20021850. View

Blom T, Franzen A, Heinegard D, Holmdahl R . Comment on "The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease". Science. 2003; 299(5614):1845; author reply 1845. DOI: 10.1126/science.1080223. View

Kagari T, Tanaka D, Doi H, Shimozato T . Essential role of Fc gamma receptors in anti-type II collagen antibody-induced arthritis. J Immunol. 2003; 170(8):4318-24. DOI: 10.4049/jimmunol.170.8.4318. View

Matsumoto I, Lee D, Goldbach-Mansky R, Sumida T, Hitchon C, Schur P . Low prevalence of antibodies to glucose-6-phosphate isomerase in patients with rheumatoid arthritis and a spectrum of other chronic autoimmune disorders. Arthritis Rheum. 2003; 48(4):944-54. DOI: 10.1002/art.10898. View

Bruhns P, Samuelsson A, Pollard J, Ravetch J . Colony-stimulating factor-1-dependent macrophages are responsible for IVIG protection in antibody-induced autoimmune disease. Immunity. 2003; 18(4):573-81. DOI: 10.1016/s1074-7613(03)00080-3. View

Nandakumar K, Andren M, Martinsson P, Bajtner E, Hellstrom S, Holmdahl R . Induction of arthritis by single monoclonal IgG anti-collagen type II antibodies and enhancement of arthritis in mice lacking inhibitory FcgammaRIIB. Eur J Immunol. 2003; 33(8):2269-77. DOI: 10.1002/eji.200323810. View

Vossenaar E, Nijenhuis S, Helsen M, van der Heijden A, Senshu T, van den Berg W . Citrullination of synovial proteins in murine models of rheumatoid arthritis. Arthritis Rheum. 2003; 48(9):2489-500. DOI: 10.1002/art.11229. View

Nandakumar K, Svensson L, Holmdahl R . Collagen type II-specific monoclonal antibody-induced arthritis in mice: description of the disease and the influence of age, sex, and genes. Am J Pathol. 2003; 163(5):1827-37. PMC: 1892447. DOI: 10.1016/S0002-9440(10)63542-0. View

10.

Gray R, Seng N, Mackay I, Rowley M . Measurement of antibodies to collagen II by inhibition of collagen fibril formation in vitro. J Immunol Methods. 2004; 285(1):55-61. DOI: 10.1016/j.jim.2003.11.010. View

11.

Schubert D, Maier B, Morawietz L, Krenn V, Kamradt T . Immunization with glucose-6-phosphate isomerase induces T cell-dependent peripheral polyarthritis in genetically unaltered mice. J Immunol. 2004; 172(7):4503-9. DOI: 10.4049/jimmunol.172.7.4503. View

12.

Hietala M, Nandakumar K, Persson L, Fahlen S, Holmdahl R, Pekna M . Complement activation by both classical and alternative pathways is critical for the effector phase of arthritis. Eur J Immunol. 2004; 34(4):1208-16. DOI: 10.1002/eji.200424895. View

13.

Feldmann M, Brennan F, Williams R, Woody J, Maini R . The transfer of a laboratory based hypothesis to a clinically useful therapy: the development of anti-TNF therapy of rheumatoid arthritis. Best Pract Res Clin Rheumatol. 2004; 18(1):59-80. DOI: 10.1016/j.berh.2003.09.010. View

14.

Akilesh S, Petkova S, Sproule T, Shaffer D, Christianson G, Roopenian D . The MHC class I-like Fc receptor promotes humorally mediated autoimmune disease. J Clin Invest. 2004; 113(9):1328-33. PMC: 398424. DOI: 10.1172/JCI18838. View

15.

Ichiyama H, Onodera S, Nishihira J, Ishibashi T, Nakayama T, Minami A . Inhibition of joint inflammation and destruction induced by anti-type II collagen antibody/lipopolysaccharide (LPS)-induced arthritis in mice due to deletion of macrophage migration inhibitory factor (MIF). Cytokine. 2004; 26(5):187-94. DOI: 10.1016/j.cyto.2004.02.007. View

16.

Wipke B, Wang Z, Nagengast W, Reichert D, Allen P . Staging the initiation of autoantibody-induced arthritis: a critical role for immune complexes. J Immunol. 2004; 172(12):7694-702. DOI: 10.4049/jimmunol.172.12.7694. View

17.

Edwards J, Szczepanski L, Szechinski J, Filipowicz-Sosnowska A, Emery P, Close D . Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis. N Engl J Med. 2004; 350(25):2572-81. DOI: 10.1056/NEJMoa032534. View

18.

Sehnert B, Cavcic A, Bohm B, Kalden J, Nandakumar K, Holmdahl R . Antileukoproteinase: modulation of neutrophil function and therapeutic effects on anti-type II collagen antibody-induced arthritis. Arthritis Rheum. 2004; 50(7):2347-59. DOI: 10.1002/art.20339. View

19.

Amirahmadi S, Pho M, Gray R, Crombie D, Whittingham S, Zuasti B . An arthritogenic monoclonal antibody to type II collagen, CII-C1, impairs cartilage formation by cultured chondrocytes. Immunol Cell Biol. 2004; 82(4):427-34. DOI: 10.1111/j.0818-9641.2004.01267.x. View

20.

Kamei D, Yamakawa K, Takegoshi Y, Mikami-Nakanishi M, Nakatani Y, Oh-Ishi S . Reduced pain hypersensitivity and inflammation in mice lacking microsomal prostaglandin e synthase-1. J Biol Chem. 2004; 279(32):33684-95. DOI: 10.1074/jbc.M400199200. View